Corline Biomedical AB (STO:CLBIO)
Sweden flag Sweden · Delayed Price · Currency is SEK
17.60
+0.05 (0.28%)
Jul 24, 2026, 3:35 PM CET

Corline Biomedical AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
32.920.5617.6717.0126.2141.64
Cash & Short-Term Investments
32.920.5617.6717.0126.2141.64
Cash Growth
180.38%16.35%3.86%-35.09%-37.05%367.55%
Accounts Receivable
5.481.612.931.662.3
Other Receivables
0.80.711.632.296.820.47
Total Trade Receivables
6.292.312.635.228.472.77
Inventory
0.82-----
Other Current Assets
1.021.120.751.571.310.42
Total Current Assets
41.0323.9821.0423.83644.82
Net Property, Plant & Equipment
0.50.160.220.310.280.18
Other Intangible Assets
74.4574.4373.575.9965.556.66
Long-Term Investments
-00000
Total Assets
115.9798.5894.76100.11101.78101.66
Accounts Payable
1.150.933.091.974.341.96
Accrued Expenses
3.783.182.853.532.454.56
Other Current Liabilities
1.480.711.911.290.42.91
Total Current Liabilities
6.44.827.856.797.199.43
Other Long-Term Liabilities
18.26-----
Total Long-Term Liabilities
18.26-----
Total Liabilities
24.664.827.856.797.199.43
Common Stock
-3.23.062.692.692.69
Additional Paid-in Capital
-192.81171.39155.19155.19155.19
Accumulated Other Comprehensive Income
-61.5260.5863.0852.5943.75
Retained Earnings
--163.77-148.12-127.64-115.88-109.39
Total Common Shareholders' Equity
-93.7686.9193.3294.5992.23
Shareholders' Equity
100.4593.7686.9193.3294.5992.23
Total Liabilities & Equity
115.9798.5894.76100.11101.78101.66
Net Cash (Debt)
32.920.5617.6717.0126.2141.64
Net Cash Growth
60.07%16.35%3.86%-35.09%-37.05%367.55%
Net Cash Per Share
1.310.830.810.791.192.04
Book Value
-93.7686.9193.3294.5992.23
Book Value Per Share
-3.793.984.344.304.51
Tangible Book Value
-74.4519.3313.4217.3229.0935.58
Tangible Book Value Per Share
-2.980.780.620.811.321.74